BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  With Aduhelm Approved, Biogen’s R&D Head Will Retire

  Biogen announced that after 23 years with the company, Alfred W. Sandrock Jr. will retire on Dec. 31. Sandrock had his hand in the development of multiple treatments for neurological diseases.

  November 16, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Race is Heating Up for the First Vaccine for RSV

  Respiratory Syncytial Virus has been around for a very long period now. But there was no vaccine yet. But, here’s the first vaccine for RSV to shape the future.

  November 16, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  “Elite Controllers” Give Hope for an HIV Cure

  Researchers have published a study of a woman being called the “Esperanza patient,” one of what researchers call “elite controllers,” who seem to eradicate HIV naturally.

  November 16, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  COVID-19 Vaccines Not Linked to Menstrual Changes; Possible Link Between SSRIs and Survival

  Earlier studies suggest a correlation between COVID-19 vaccines and menstrual changes. A new study says otherwise.

  November 16, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Heart Disease Therapies Pack a Punch with Promising Study Results

  Three companies have posted major developments in the field of heart disease therapy.

  November 16, 2021

   · 

  5 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  End-of-Year Restructuring Means Layoffs for These Companies

  It’s not unusual for biopharma companies to end the year with a restructuring that includes job cuts. Here are some of these companies.

  November 16, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  AAV Pioneer Guangping Gao Created Hope for Canavan Disease Cure

  After 32 years, gene therapy pioneer Guangping Gao, Ph.D., is finally seeing the fruits of the doctoral thesis research he started in 1989.

  November 16, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Drug Development

  Nasal Vaccine Starts Trial to Protect Against Alzheimer’s

  Scientists from Brigham and Women’s Hospital are ready to start a clinical trial that will evaluate the use of an intranasal vaccine to prevent Alzheimer’s disease.

  November 16, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Deals

  AcelRx to Buy Lowell Therapeutics; Kala Expands Pipeline with Combangio Acquisition

  AcelRx Pharmaceuticals and Kala Pharmaceuticals both shared acquisition news on Monday. Here’s a closer look at each of the acquisition announcements.

  November 16, 2021

   · 

  2 min read

   · 

  Ellen Camacho
• 

  Business

  Chroma Medicine Nets $125 Million to Harness Nature’s Genomic Gatekeeper

  Chroma Medicine debuted Wednesday morning with $125 million in seed and Series A funding.

  November 16, 2021

   · 

  3 min read

   · 

  Heather McKenzie